2020
DOI: 10.1016/j.jece.2019.103560
|View full text |Cite
|
Sign up to set email alerts
|

Cobalt (II/III) oxide and tungsten (VI) oxide p-n heterojunction photocatalyst for photodegradation of diclofenac sodium under visible light

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
14
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 79 publications
(15 citation statements)
references
References 84 publications
0
14
0
1
Order By: Relevance
“…The reduction in electron and hole recombination of WO 3 can also occur with nanocomposites of cobalt(II, III) oxide and tungsten(VI) oxide. The synthesis of p-n heterojunction catalysts, such as Co 3 O 4 /WO 3 , was claimed to enhance the photoactivity under UV-or visible-light radiation [420]. The strong reduction in photoexcited electrons and holes resulted in the enhancement in diclofenac sodium degradation.…”
Section: Zno-womentioning
confidence: 99%
See 1 more Smart Citation
“…The reduction in electron and hole recombination of WO 3 can also occur with nanocomposites of cobalt(II, III) oxide and tungsten(VI) oxide. The synthesis of p-n heterojunction catalysts, such as Co 3 O 4 /WO 3 , was claimed to enhance the photoactivity under UV-or visible-light radiation [420]. The strong reduction in photoexcited electrons and holes resulted in the enhancement in diclofenac sodium degradation.…”
Section: Zno-womentioning
confidence: 99%
“…Higher generation of hydroxyl radicals (OH•) associated with the enhancement of effective charge separation was still advanced to explain the high photocatalytic activity of the CW2 sample. Figure 34 shows the charge transfer proposed by Malefane et al [420] and the p-n heterojunction formed to minimize photoexcited electron and hole recombination in CW2 nanocomposite. Among the post-transition metals, bismuth and gallium were evaluated in recently published works.…”
Section: Zno-womentioning
confidence: 99%
“…Type III system 22 The CB and VB of one semiconductor is between another Two systems are used and may possess different properties from the single components and increase light absorption range The exciton pair separation is not achieved; less stability of the system as redox reactions happen on one semiconductor p-n heterojunction 23 One semiconductor is a p-type and another one is an n-type Efficiently separate electrons and holes, improves photo- single photosystem. The developed heterostructures can be classified based on the direction and type of interaction and electron transfer as type I, type II, type III, and recently Zscheme heterojunctions.…”
Section: Uses Very Costly Noble Metalsmentioning
confidence: 99%
“…Formation of heterojunction photocatalysts is employed to improve the performance of individual semiconductor photocatalysts through a combination of two or more semiconductors in a single photosystem. The developed heterostructures can be classified based on the direction and type of interaction and electron transfer as type I, type II, type III, and recently Z-scheme heterojunctions. , The type I heterojunction is often referred to as the broken gap with a gap between the VB of one semiconductor (SC I) and the CB of the second semiconductor (SC II) without attainment of any possibility for electron and hole separation, which makes it unsuitable for photocatalytic applications (Figure c). The type III semiconductor heterostructure involves charge transfer from SC II to SC I such that all exciton pairs accumulate on the VB and CB of SC I due to its band edge positions being lower than that of SC II (Figure d).…”
mentioning
confidence: 99%
“…Diverse tactics investigated for possible improvement of the general efficiency of semiconductors for removal of pharmaceuticals include metal doping [9] , non-metal doping [10] , multi-elemental doping with metals and/or non-metals [11] , use of supports [12] , and formation of heterojunctions [13] , [14] . The contribution of heterojunctions towards abatement of different classes of pharmaceuticals such as β- blockers, hormones, antibiotics, cholesterol-lowering drugs, oestrogens, anti-psychotics, non-steroidal anti-inflammatory drugs (NSAIDs) and analgesics has been studied recently [15] , [16] , [17] , [18] , [19] , [20] .…”
Section: Introductionmentioning
confidence: 99%